Drug Type AAV based gene therapy |
Synonyms secreted alpha Klotho gene therapy (Klogene Therapeutics) |
Target |
Action agonists |
Mechanism KLB agonists(Klotho beta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | United States | - |